logo
Select company
Select metric
101.9%Capital Expenditures to Operating Cash Flow
VS
Market
13
Sector
8
Industry
9
History
21
$ 10.33Close
$ 1.59 - $ 10.63 52-Week Range
Ticker Information

Ticker

AIRS

Company Name

AIRSCULPT TECHNOLOGIES INC

Sector

Healthcare

Industry

Medical Care Facilities

Exchange

NASDAQ

AIRSCULPT TECHNOLOGIES INC - Capital Expenditures to Operating Cash Flow Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

AIRS - CapEx/OCF Historical data
DateCapital ExpenditureCapital Expenditures to Operating Cash FlowNet Cash Flow - Operations
6/30/2025$ 10.59M101.9%$ 10.39M
3/31/2025$ 14.35M162.05%$ 8.85M
12/31/2024$ 14.01M123.41%$ 11.35M
9/30/2024$ 12.31M91.14%$ 13.5M
6/30/2024$ 9.52M77.37%$ 12.31M
3/31/2024$ 7.67M36.33%$ 21.1M
12/31/2023$ 9.92M41.41%$ 23.96M
9/30/2023$ 10.29M39.98%$ 25.73M
6/30/2023$ 12.76M50.18%$ 25.42M
3/31/2023$ 12.46M52.84%$ 23.59M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • AIRSCULPT TECHNOLOGIES INC's latest trailing twelve months (TTM) CapEx/OCF stands at 26.43%.
  • Over the past 5 years, AIRSCULPT TECHNOLOGIES INC's average CapEx/OCF has been 69.39%.
  • The median CapEx/OCF for AIRSCULPT TECHNOLOGIES INC during this period was 52.84%
  • AIRSCULPT TECHNOLOGIES INC reached its highest CapEx/OCF over the past 5 years at 162.05%.
  • The lowest CapEx/OCF recorded by AIRSCULPT TECHNOLOGIES INC in the same timeframe 26.43%

AIRSCULPT TECHNOLOGIES INC's CapEx/OCF vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CapEx/OCF Benchmarks
CompanyCapEx/OCF
PACB : PACIFIC BIOSCIENCES OF CALIFORNIA INC -RGNX : REGENXBIO INC -SPOK : SPOK HOLDINGS INC 12.1%NRC : NATIONAL RESEARCH CORP 56.49%CTMX : CYTOMX THERAPEUTICS INC -BTMD : BIOTE CORP 16.55%RXST : RXSIGHT INC -TMCI : TREACE MEDICAL CONCEPTS INC -LAB : STANDARD BIOTOOLS INC -TALK : TALKSPACE INC 89.52%

Definition of Capital Expenditures to Operating Cash Flow

[Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
CapEx / CF - Operations
(=) CapEx/OCF
CapEx/OCF for AIRSCULPT TECHNOLOGIES INC is calculated as follows: CapEx [ $ 3.69M ] / CF - Operations [ $ 13.96M ]
(=) CapEx/OCF [ 26.43% ]

AIRS - Capital Expenditures to Operating Cash Flow, Last 5 years

26.43%

Minimum

Dec 31, 2020

162.05%

Maximum

Mar 31, 2025

69.39%

Average

52.84%

Median

CapEx/OCF Benchmark Analysis

The chart above depicts the distribution of CapEx/OCF for companies in the Total Stock Market. The average CapEx/OCF of the companies is 31.8% with a standard deviation of 29.52%.
The following table provides additional summary stats:
CapEx/OCF in the Market:
filtered constituents2.35K
min0.01%
max128%
average31.8%
median22.41%
std29.52%